about
Proteome analysis of schizophrenia patients Wernicke's area reveals an energy metabolism dysregulationMaking Sense of Blood-Based Proteomics and Metabolomics in Psychiatric ResearchAnalysis of the rat hypothalamus proteome by data-independent label-free LC-MS/MS.Proteomics, metabolomics, and protein interactomics in the characterization of the molecular features of major depressive disorder.Structural and pharmacological characterization of the crotamine isoforms III-4 (MYX4_CROCu) and III-7 (MYX7_CROCu) isolated from the Crotalus durissus cumanensis venom.Unveiling alterative splice diversity from human oligodendrocyte proteome data.Proteome analysis of the plant pathogen Xylella fastidiosa reveals major cellular and extracellular proteins and a peculiar codon bias distribution.Absence of classical heat shock response in the citrus pathogen Xylella fastidiosa.The use of ASB-14 in combination with CHAPS is the best for solubilization of human brain proteins for two-dimensional gel electrophoresis.Structural and biological characterization of two crotamine isoforms IV-2 and IV-3 isolated from the Crotalus durissus cumanensis venom.The Application of Multiplex Biomarker Techniques for Improved Stratification and Treatment of Schizophrenia Patients.Application of Proteomic Techniques for Improved Stratification and Treatment of Schizophrenia Patients.Structural and functional characterization of brazilitoxins II and III (BbTX-II and -III), two myotoxins from the venom of Bothrops brazili snake.Biological and biochemical characterization of two new PLA2 isoforms Cdc-9 and Cdc-10 from Crotalus durissus cumanensis snake venom.Shotgun mass spectrometry workflow combining IEF and LC-MALDI-TOF/TOF.Purification and characterization of a new weak hemorrhagic metalloproteinase BmHF-1 from Bothrops marajoensis snake venom.Biochemical and pharmacological characterization of PhTX-I a new myotoxic phospholipase A2 isolated from Porthidium hyoprora snake venom.Sex-specific proteome differences in the anterior cingulate cortex of schizophrenia.The role of proteomics in depression researchThe application of selective reaction monitoring confirms dysregulation of glycolysis in a preclinical model of schizophrenia.Proteomic analysis identifies dysfunction in cellular transport, energy, and protein metabolism in different brain regions of atypical frontotemporal lobar degeneration.Proteome analysis of spinal cord during the clinical course of monophasic experimental autoimmune encephalomyelitis.Disturbed macro-connectivity in schizophrenia linked to oligodendrocyte dysfunction: from structural findings to molecules.Alterations in oligodendrocyte proteins, calcium homeostasis and new potential markers in schizophrenia anterior temporal lobe are revealed by shotgun proteome analysis.Proteomic analysis of dorsolateral prefrontal cortex indicates the involvement of cytoskeleton, oligodendrocyte, energy metabolism and new potential markers in schizophrenia.Prefrontal cortex shotgun proteome analysis reveals altered calcium homeostasis and immune system imbalance in schizophrenia.Deciphering the human brain proteome: characterization of the anterior temporal lobe and corpus callosum as part of the Chromosome 15-centric Human Proteome Project.MK-801 treatment affects glycolysis in oligodendrocytes more than in astrocytes and neuronal cells: insights for schizophrenia.The proteome of schizophrenia.Plasma fibrinogen: now also an antidepressant response marker?Proteome analysis of schizophrenia brain tissue.The role of energy metabolism dysfunction and oxidative stress in schizophrenia revealed by proteomics.Quantitative proteomics for investigating psychiatric disorders.Proteomic technologies for biomarker studies in psychiatry: advances and needs.Abnormalities in metabolism and hypothalamic-pituitary-adrenal axis function in schizophrenia.To label or not to label: applications of quantitative proteomics in neuroscience research.Proteomic approaches to unravel the complexity of schizophrenia.Comprehending depression through proteomics.Using mass spectrometry-based peptidomics to understand the brain and disorders such as Parkinson's disease and schizophrenia.Ten years of proteomics in multiple sclerosis.
P50
Q21260256-F858CEAA-3BE7-4B0C-BE62-311A0CCBBFB7Q26771434-5AAE3ACB-757B-44BE-BB48-1AF602A7CAFFQ30569671-EBBE60AA-9D34-43E7-804C-986F3EC46B67Q30801268-DAE9A3AC-A934-4D48-8FA0-A96C34BED66DQ30979129-5BA99F2B-C073-41E1-B9B6-A83AFA0875DEQ31101536-6D621643-F8E3-4CB4-A0BF-9B29BE29B1BBQ33186155-5ABDEB36-04A2-465B-BFD5-DAB7F2E96ACEQ33268636-1F3C4B89-5D1A-4D96-9BF4-B5E41B12E5E0Q33287085-DBA9799B-F768-49F4-ACCC-DAE958F406A9Q33298082-CDF5CDB6-7DA8-43F8-BDE8-1A9AB46DAB27Q33451672-D42BD302-1260-4B04-9665-FCDD94985AADQ33453744-09A27F82-5674-4957-8340-70161085E353Q33470819-D196F8BF-5E4A-4CE6-B711-050EB0A8C240Q33502441-3E716994-0652-48E8-92D1-153DE94DE2DFQ33525630-C277DA01-971A-4B49-976F-2CDFDA0A258DQ33626504-F112ED41-B47F-4A43-8741-4E576FE3889BQ33874590-026099E8-1735-4FDA-9F15-ABEBB90F0905Q34109438-7F38BF7B-80DE-40EE-9B3A-59C0A5D10C93Q34130553-AC8C6D53-9C49-40BF-8D85-4F88FF48E8FAQ34197032-A37C72A2-8E86-48F7-A205-BFF59B8280E2Q34256510-FABF4672-3337-4145-9AD8-0C068A987C32Q34319492-B98DC14C-4643-439E-9EA8-D8B907EB2852Q34531769-64BF3705-A3AE-4CCA-A832-BB815E9FD399Q34888915-786EF12A-E30B-451C-9932-E761346F854CQ34911118-50080997-E7D6-416F-819D-4CCD69822AF2Q34928687-BA5C6AAB-A8BB-4A9C-ACA1-8F8FCA554C69Q35052619-7D50ADF3-2D6B-4BE5-A505-2CAA5034317BQ35598966-E354736E-C150-4EA9-B58C-C6590920CFB2Q36848272-50C106BF-733F-4B25-87A4-4AC4AB01C253Q37526450-5FC0457C-34AC-4853-9FEE-1D2425B28F90Q37682924-10B51110-F096-4CBB-BD09-107D9F2DC93EQ37776737-DA2E027A-CD32-46BC-A63B-E737FBBC8376Q37833588-518F7868-EC29-4C19-BD98-A4CB22EE246DQ37952388-F836CD64-04CE-4F39-B29F-1BCECA68EE83Q37952391-70648AB6-AEBC-43CA-893A-302B685FCAC6Q37976002-D8050E51-3F3E-4E5E-AD74-23156CF3D426Q37980246-D18EBD20-6E89-4FD8-B37F-50EECA2C838FQ38020290-52058BA4-5399-4334-8756-D9ECB2F25CEFQ38168607-217C3653-6CF9-4F80-8272-64057DEC3C92Q38171465-0EB8F409-4B16-4246-BFB2-1F93D1245781
P50
subject
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Daniel Martins-de-Souza
@ast
Daniel Martins-de-Souza
@en
Daniel Martins-de-Souza
@es
Daniel Martins-de-Souza
@fr
Daniel Martins-de-Souza
@nl
Daniel Martins-de-Souza
@sl
type
label
Daniel Martins-de-Souza
@ast
Daniel Martins-de-Souza
@en
Daniel Martins-de-Souza
@es
Daniel Martins-de-Souza
@fr
Daniel Martins-de-Souza
@nl
Daniel Martins-de-Souza
@sl
prefLabel
Daniel Martins-de-Souza
@ast
Daniel Martins-de-Souza
@en
Daniel Martins-de-Souza
@es
Daniel Martins-de-Souza
@fr
Daniel Martins-de-Souza
@nl
Daniel Martins-de-Souza
@sl
P1006
P214
P1006
P1053
E-7021-2010
P106
P1153
25621529400
P21
P214
P2798
P31
P3829
P496
0000-0003-3595-5846